BloombergLean L·
India FSSAI Acts Against GLP-1 Supplement for Misleading Claims
India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.
Read at Bloomberg →
